WO1984000979A1 - Process for determining whether a herpersvirus is in the virulent or latent state - Google Patents

Process for determining whether a herpersvirus is in the virulent or latent state Download PDF

Info

Publication number
WO1984000979A1
WO1984000979A1 PCT/US1983/001209 US8301209W WO8400979A1 WO 1984000979 A1 WO1984000979 A1 WO 1984000979A1 US 8301209 W US8301209 W US 8301209W WO 8400979 A1 WO8400979 A1 WO 8400979A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
fragments
herpesvirus
dna fragments
hsv
Prior art date
Application number
PCT/US1983/001209
Other languages
French (fr)
Inventor
Nigel W Fraser
Daniel L Rock
Original Assignee
Wistar Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Inst filed Critical Wistar Inst
Publication of WO1984000979A1 publication Critical patent/WO1984000979A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster

Definitions

  • HSV-1 and HSV-2 herpes simplex virus types 1 and 2
  • HSV-1 and HSV-2 herpes simplex virus types 1 and 2
  • HSV-1 has been found in the human brain, as for example in the frontal lobe gray matter, periventricular white matter, cerebellum and pariental lobe, as well as the trigeminal ganglia.
  • HSV-1 The genome of HSV-1 is a linear double-stranded DNA of 10 8 daltons (Kieff, E.D. et al. J. Virol. 8 , 125-132 (1971)) and consists of two unique segments bounded by inverted repeats (Sheldrick, P. et al (1974) Cold Spring Harbor Symp. Quant. Biol. 39, 667-678).
  • the G + C content of the genome is unusually high (67%; Kieff et al, (1971) J. Virol. 8 , 125-132), and it is cut by restriction endonuclease BamHI (G ⁇ G-A-T-C-C) 40 times.
  • a primary object of the present invention is to provide a novel process for determining whether a herpesvirous which is believed to have infected cellular tissue is in the virulent or latent state.
  • Another object of the invention is to provide a molecular test for the presence of virulent herpes simplex virus type 1.
  • Lane 1 is an autoradiograph of blot filters showing patterns of bands as a result of digesting DNA from CV-1 cells infected with HSV-1 (F) with restriction endonuclease BamHI and hybridizing the digested DNA with 32 P-labeled nick-translated HSV-1 (F) total virion DNA probe; Lanes 2 to 13 bands from similiarly digested and hybridized DNA from mouse cell sources, and Lanes 14 and 15 represent similarly digested and hybridized DNA from uninfected mouse cell sources;
  • Fig. 2 is a map of the prototype HSV-1 genome
  • Fig. 3 is an autoradiograph generally similar to that of Fig. 1 using a 32 p-l abel ed nick-translated HSV-1 strain F (SP) fragment probe.
  • SP 32 p-l abel ed nick-translated HSV-1 strain F (SP) fragment probe.
  • the process of this invention is designed to determine whether a herpesvirus is in the active or virulent state, as compared to the latent state, in cellular tissue believed to be infected with a herpesvirus. Although the process is described in detail with respect to determining whether HSV-1 is in the active or latent state, it is to be understood that the process is equally applicable to other types of herpesviruses such as HSV-2, cytomegalovirus, Epstein-Barr virus and varicella zoster.
  • HSV-1 is found in the brain and trigeminal ganglia and may be in the active form in the absence of clinical signs of the infection.
  • brain or other cellular tissue suspected of being infected with HSV-1 is obtained and DNA is extacted therefrom.
  • the DNA so obtained is digested with a restriction endonuclease to cut the genome into a number of fragments, these fragments are separated by size, and the separated fragments are bound to filter sheets and hybridized to radio active-labeled nick-translated terminal fragments of the HSV-1 genome.
  • the resulting hybridized DNA fragments are then subjected to autoradiography, and the pattern of bands obtained is compared with the pattern of autoradiograph bands produced by the hybridization of a restriction endonuclease digest of DNA from cells infected with HSV-1 to radio active-labeled nick-translated terminal fragments of HSV-1.
  • the DNA may be extracted from the cells suspected of being infected with HSV-1 by means of the following procedure. Approximately 1 or 2 cm 3 of tissue are minced in 0.15M NaCl/0.05M EDTA/0.01 M Tris ⁇ HCl, pH 8.0, at 4°C. This material is throughly homogenized, as for example in a Dounce homogenizer, brought to a final concentration of 0.5% in NaDodSO 4 , and incubated overnight with self-digested Pronase at 500 ⁇ g/ml. The DNA is extracted with phenol/chloroform and precipitated with 2 volumes of ethanol. The precipitate is centrifuged out and dissolved in 0.01 M Tris ⁇ HCl/0.01 M EDTA, pH 7.4.
  • the preferred restriction endonuclease is BamHI since althought it cuts the terminal respeats in the HSV-1 genome (see Fig 2), it does not cut the viral genome into as many fragments as Smal and XmaI, and thus make the process somewhat less complex.
  • 20 units of the restriction endonuclease e.g. BamHI, may be used to digest 10 ⁇ g of DNA in 20 ⁇ l of 100 mM Tris ⁇ HCl, pH 8.0/7mM MgCl 2 . After incubation for 2 hours at 37°C an additional 20 units of enzyme are added and digestion is continued for a further 2 hours to minimize the possibility of partial digestion products.
  • Separation of the fragments of digested DNA by size may be accomplished by electrophores is on 0.5% agarose gels (Bio-Rad) in a borate buffer (0.09 M Tris ⁇ HCl, pH 8.3/0.9 M boric acid/0.25 M EDTA containing ethidium bromide at 0.05 ⁇ g/ml). The gels are then blotted onto nitrocellulose filters.
  • a borate buffer (0.09 M Tris ⁇ HCl, pH 8.3/0.9 M boric acid/0.25 M EDTA containing ethidium bromide at 0.05 ⁇ g/ml.
  • nick-translated terminal fragments of the same herpes viral geonme as is suspected of infecting the test cells.
  • radio active fragments may be cloned using the procedure described by Roizman, B., (1979) Cell 16 , 481-494.
  • nick-translated probes of the total virion may be prepared by the techniques of Maniatis, T. et al (1976) Cell 8, 163-182, and Rigby , P.W. J., et al (1977) J. Mol. Biol. 113, 237.
  • radio active probes for use in the process of the present invention are cloned 32p-l abeled nick-translated (SP) terminal fragments of the HSV-1 viral genome prepared by the method of Roizman B., supra.
  • blots Following transfer of DNA fragments onto nitrocellulose filters, the transferred fragments, referred to in the art as "blots", are hybridized to the radio active nick-translated terminal fragment probes of the type described hereinabove.
  • the "blot" filters are maintained in 10 ml of 20% formamide/0.6M NaCl/0.06 M sodium citrate/0.01 M EDTA/0.1 to NaDodSO 4 /5-fold Denhardt's solution (see Denhardt, D. (1966) Biochem. Biophys. Res. Commun. 23, 641-646) containing sonicated denatured salmon sperm DNA at 50 ⁇ g/ml in 1/2 gal plastic bottles at 50°C on a standard tissue culture roller bottles apparatus for 5-16 hours prior to addition of denatured radio active probe (1-5x10 7 cpm per filter).
  • Hybridization is carried out during a period of 36 hours at 50°C in 50% formamide/10% dextran sulfate (see Wohl et al supra)/Denhardt's solution/4-fold standard saline citrate (NaCl/Cit/0.1M EDTA/0.1% NaDodSO 4 containing sonicated denatured salmon sperm DNA at 25 ⁇ g/ml.
  • the nitrocellulose filters are rinsed twice with 5-fold NaCl/Cit/0.1% NaDodSO 4 at 50°C for 10 minutes each and then for 20 minutes with hybridized mixture without salmon sperm DNA and dextran sulfate at 50°C.
  • the filters are rinsed once in NaCl/Cit/0.1% NaDodSO 4 at 37°C for 20 minutes, once in NaCl/Cit/0.1% NaDodSO 4 at 65°C for 20 minutes, once in half-strength NaCl/Cit/0.1% NaDodSO 4 at 65°C for 20 minutes and finally in quarter-strength NaCl/Cit/0.1% NaDodSO 4 at 65°C for 15 minutes.
  • the filters are blotted dry and autoradiographed with XR film and DuPont Cronex Lighting Plus screens at -70°C for 1-10 days.
  • a control hybridized restriction enzyme digest of DNA from cells infected with the same type of virulent herpesvirus as that believed to infect the test cells to radio active-labeled nick-translated terminal fragments of the same herpesvirus genome is prepared using the above described procedures, and subjected to autoradiography.
  • the respective autoradiographs of the test specimens are compared to those of the latter known control specimens and matching bands representing terminal fragments of the viral genome indicate the presence of virulent herpesvirus in the test specimen.
  • Whether the test cells are infected with a herpes virus will also be indicated by the correlation of other bands of the respective specimens, the absence of bands representing the terminal fragments indicating that the virus is in the latent state.
  • Example I The purpose of this example is to determine the presence of HSV-1 in the cellular tissue of the test animals.
  • BALB/c mice were infected with HSV-1(F) by corneal scarification and DNA was extracted from mouse brain and ganglia at acute and latent stages of infection (see Puga, A et al, (1979) Virology 89, 102-111).
  • DNA was extracted from ganglia and brains of latently infected mice, digested with restriction endonuclease BamHI, the DNA fragments were separated by agarose gel electrophoresis, the separated fragments were transferred to nitrocellulose filters and hybr idized to cloned 32p-labeled, n ick-translated fragments of the HSV-1 total viral genome using the procedure which has been detailed hereinabove.
  • the control was similarly prepared using DNA from the HSV-1 (F) strain which was grown on CV-1 and baby hamster kidney (BHK)-21 cells. Autoradiographic exposures ranged from 1 to 6 days.
  • Fig. 1 shows a selection of acutely infected and latently infected mouse brain and ganglia DNA.
  • Lane 1 the control, represents 1.0 ng. of HSV-1 (F) DNA, purified from extracellar virions and 10 ⁇ g of uninfected CV-1 cell DNA.
  • Lanes 2 to 6 represent 20 ⁇ g of mouse brain DNA taken from five acutely infected mice (6 days post inoculation).
  • Lanes 7, 8 and 10 to 13 represent 20 ⁇ g of brain DNA taken from six latently infected mice (2 months post inoculation).
  • Lane 9 represents 20 ⁇ g of DNA extracted from pooled latently infected trigeminal ganglia (2 mo. PI).
  • Lanes 14 and 15 represent 20 ⁇ g of brain DNA taken from each of two uninfected control animals. Using the above technique where total viron
  • DNA was extracted from whole brain at various times PI or from brain regions at 2 mo. PI twenty ⁇ g samples of brain DNA were digested with BamHI, electrophoresed in agarose gels, transferred to nitrocellulose filters, and hybridized with 32 P labeled HVS-1 strains (F) DNA. Genome equivalents was approximated by visual comparison of the sample autoradiographic image with that of reconstructed standards.
  • (+) denotes a sample positive for HSV-1 DNA with 0.15-0.015 genome equivalents per cell
  • (+) indicates the sample contained about 0.15 but less than 1.5 genome equivalents per cell
  • (+) denotes samples that were negative for HSV-1 DNA under the assay conditions.
  • the stem which constitutes about 1/15 (50 ⁇ g) of the brain DNA appears to be rich in latent viral DNA which is to be expected if the method of brain infection by HSV-1 is via the trigemenal nerve route.
  • the prototype HSV-1 (F) genome there shown consists of a long unique region (U L ) and short unique regions (U s ). Both unique regions are bounded by inverted repeat regions (TR L , IR L , IR S , TR S ).
  • the long and short segments of the genome invert relative to one another forming four isomers.
  • the fragment BamHI SP which spans the junction of the long and short segments of the genome is totally within the IR L and IR S regions resulting in a single BamHI junction fragment for all isomers.
  • Cloned viral fragments used as probes in blot hydridization expermiments are localized along the genome map.
  • the genome illustrated in Fig. 2 is divided into 100 map units, each of which represents 0.98 x 10 6 daltons or approximately 1.63 kilobases.
  • EXAMPLE 2 Rather than using total virion DNA as the probe for viral sequences as in Example 1, the probe used was the BamHI fragment SP corresponding to the termini and joint regions (see Fig. 2), which was hybridized with virion DNA (control) and mice brain DNA.
  • Fig. 3 shows a blot hybridization using BamHI (SP) fragment DNA as the probe.
  • Lane 1 viral DNA control
  • Lanes 2 to 4 acute brain DNA
  • Lanes 5 to 9 show brains infected wth latent virus and no terminal fragments can be seen. Densitometer scans for the virion, acute and latent autoradiographs showed a molar ratio relative to the PS joint fragment of 0.3 for the P and S terminal fragments during acute infection. That the terminal fragments are reduced in molarity during acute infection of neural tissue with HSV-1 is not unusual. It has previously been noted in infected tissue cells (see Jacob, R.J. et al. (1979) Virology 29. 448-457).

Abstract

A test for determining whether a herpesvirus present in cellular tissue is in the virulent or latent state which comprises extracting DNA from cells suspected of being infected with a herpesvirus, digesting the DNA with a restriction endonuclease, separating the resulting DNA fragments by size, transferring the separated DNA fragments to a nitrocellulose sheet, hybridizing the separated DNA fragments to radio active-labelled nick-translated terminal fragments of the herpes viral genome, subjecting said hybridized DNA fragments to autoradiography, and comparing the pattern of autoradiograph bands obtained with the pattern of autoradiograph bands produced by the hybridization of a restriction enzyme digest of DNA from cells infected with the same type of virulent herpesvirus to radio active-labelled nick-translated terminal fragments of the herpesvirus genome.

Description

Description Process for Determining whether a Herpesvirus Is in the Virulent or Latent State
Four types of human herpesviruses can be identified: cytomegalovirus, Epstein-Barr virus, varicella zoster virus, and herpes simplex virus types 1 and 2 (HSV-1 and HSV-2, respectively). Of these HSV-1 has been studied most and, almost from its discovery, has been known by its ability to form latent infections in nervous tissue (Goodpasture, E.W. (1929) Medicine
(Baltimore) 8, 223). The virus reactivates periodically to produce recurrent disease (Stevens, J.G., (1978) Adv. Cancer Res. 26, 227-257; Klein, R.J. (1982) Archives of Virology 72, 143-168). HSV-1 has been found in the human brain, as for example in the frontal lobe gray matter, periventricular white matter, cerebellum and pariental lobe, as well as the trigeminal ganglia.
The genome of HSV-1 is a linear double-stranded DNA of 108 daltons (Kieff, E.D. et al. J. Virol. 8 , 125-132 (1971)) and consists of two unique segments bounded by inverted repeats (Sheldrick, P. et al (1974) Cold Spring Harbor Symp. Quant. Biol. 39, 667-678). The G + C content of the genome is unusually high (67%; Kieff et al, (1971) J. Virol. 8 , 125-132), and it is cut by restriction endonuclease BamHI (G↓G-A-T-C-C) 40 times.
There has been a need not only to detect the presence of herpesvirus in cellular tissue, but also to determine whether it is in the virulent, as compared to the latent stage, in the absence of clinical signs of the disease, such as cold sores, since the virus, when virulent, is some instances, can and does attack and destroy portions of the brain. Objects of the Invention
A primary object of the present invention is to provide a novel process for determining whether a herpesvirous which is believed to have infected cellular tissue is in the virulent or latent state.
Another object of the invention is to provide a molecular test for the presence of virulent herpes simplex virus type 1.
These and other objects of this invention will become apparent from the following specfication, appended claims, and drawings, in which:
Fig. 1, Lane 1, is an autoradiograph of blot filters showing patterns of bands as a result of digesting DNA from CV-1 cells infected with HSV-1 (F) with restriction endonuclease BamHI and hybridizing the digested DNA with 32P-labeled nick-translated HSV-1 (F) total virion DNA probe; Lanes 2 to 13 bands from similiarly digested and hybridized DNA from mouse cell sources, and Lanes 14 and 15 represent similarly digested and hybridized DNA from uninfected mouse cell sources;
Fig. 2 is a map of the prototype HSV-1 genome, and
Fig. 3 is an autoradiograph generally similar to that of Fig. 1 using a 32p-l abel ed nick-translated HSV-1 strain F (SP) fragment probe. Details of the Invention The process of this invention is designed to determine whether a herpesvirus is in the active or virulent state, as compared to the latent state, in cellular tissue believed to be infected with a herpesvirus. Although the process is described in detail with respect to determining whether HSV-1 is in the active or latent state, it is to be understood that the process is equally applicable to other types of herpesviruses such as HSV-2, cytomegalovirus, Epstein-Barr virus and varicella zoster.
As noted above, HSV-1 is found in the brain and trigeminal ganglia and may be in the active form in the absence of clinical signs of the infection. In the process of the invention, brain or other cellular tissue suspected of being infected with HSV-1 is obtained and DNA is extacted therefrom. The DNA so obtained is digested with a restriction endonuclease to cut the genome into a number of fragments, these fragments are separated by size, and the separated fragments are bound to filter sheets and hybridized to radio active-labeled nick-translated terminal fragments of the HSV-1 genome. The resulting hybridized DNA fragments are then subjected to autoradiography, and the pattern of bands obtained is compared with the pattern of autoradiograph bands produced by the hybridization of a restriction endonuclease digest of DNA from cells infected with HSV-1 to radio active-labeled nick-translated terminal fragments of HSV-1.
The DNA may be extracted from the cells suspected of being infected with HSV-1 by means of the following procedure. Approximately 1 or 2 cm3 of tissue are minced in 0.15M NaCl/0.05M EDTA/0.01 M Tris·HCl, pH 8.0, at 4°C. This material is throughly homogenized, as for example in a Dounce homogenizer, brought to a final concentration of 0.5% in NaDodSO4, and incubated overnight with self-digested Pronase at 500μg/ml. The DNA is extracted with phenol/chloroform and precipitated with 2 volumes of ethanol. The precipitate is centrifuged out and dissolved in 0.01 M Tris· HCl/0.01 M EDTA, pH 7.4. Ribonuclease A is added to 40 mg/ml, the solution is incubated at 37°C for 2 hours, extracted with phenol, and the DNA is precipitated with ethanol. The DNA recovered is quantitated by measuring A260 (1 μg/ml = 0.02 A unit). The DNA so extracted is then digested with a restriction endonuclease, examples of which are BamHI, Smal, and XmaI, all of which are available from New England Bio Labs. BamHI and Smal are also available from Bethesda Research Laboratories, Inc. The preferred restriction endonuclease is BamHI since althought it cuts the terminal respeats in the HSV-1 genome (see Fig 2), it does not cut the viral genome into as many fragments as Smal and XmaI, and thus make the process somewhat less complex. In the digestion step 20 units of the restriction endonuclease, e.g. BamHI, may be used to digest 10μg of DNA in 20 μl of 100 mM Tris· HCl, pH 8.0/7mM MgCl2. After incubation for 2 hours at 37°C an additional 20 units of enzyme are added and digestion is continued for a further 2 hours to minimize the possibility of partial digestion products.
Separation of the fragments of digested DNA by size may be accomplished by electrophores is on 0.5% agarose gels (Bio-Rad) in a borate buffer (0.09 M Tris· HCl, pH 8.3/0.9 M boric acid/0.25 M EDTA containing ethidium bromide at 0.05μg/ml). The gels are then blotted onto nitrocellulose filters. For further details of the steps of restriction endonuclease digestion, electrophoresis and transfer or blotting into nitrocellulose sheets, see Southern, E.M. (1975) J. Mol. Biol. 98, 503-517 and Wahl, G.M. et al, (1979) Proc. Natl. Acad. Sci. USA 76, 3683-3687.
As noted above, after transfer of the separated DNA fragments onto the nitrocellulose sheets or filters, the fragements are hybridized to radio active-labeled nick-translated terminal fragments of the same herpes viral geonme as is suspected of infecting the test cells. These radio active fragments may be cloned using the procedure described by Roizman, B., (1979) Cell 16 , 481-494. In order to determine the presence of the virus, nick-translated probes of the total virion may be prepared by the techniques of Maniatis, T. et al (1976) Cell 8, 163-182, and Rigby , P.W. J., et al (1977) J. Mol. Biol. 113, 237. In such procedure, to 0.25μg of HSV-1 DNA purified from virions in 25μl of 50mM Tris· HCl/5mM Mg Cl2/bovine serum albumen (50μg/ml)/1mM dGPT/1mM dTTP are added 100 Ci(1 Ci=3.7x1010 becquerels ) of [α-32p ] dCTP ( Amersham ; 200-300 C i/mM ) , 2x10-4 Kunitz units of DNase 1 (Worthington), and 2 units of DNA polymerase purified from E. Coli
(Boehringer Mannheim). The reaction mixture is incubated at 15°C for 2 hours, and then 100μl of 0.1 M NaCl/10mM Tris· HCl, pH 7.4/1mM EDTA/0.1% NaDodSO4 containing 50 μg of sonicated salmon sperm DNA is added. The solution is passed through a Sephadex G-50 column, and the peak fractions of DNA are ethanol precipated, specific activies of 3-7 x 108 cpm/g ordinarily may be achieved with a 30-50% incorporation of label. Preferred radio active probes for use in the process of the present invention are cloned 32p-l abeled nick-translated (SP) terminal fragments of the HSV-1 viral genome prepared by the method of Roizman B., supra.
Following transfer of DNA fragments onto nitrocellulose filters, the transferred fragments, referred to in the art as "blots", are hybridized to the radio active nick-translated terminal fragment probes of the type described hereinabove.
The "blot" filters are maintained in 10 ml of 20% formamide/0.6M NaCl/0.06 M sodium citrate/0.01 M EDTA/0.1 to NaDodSO4/5-fold Denhardt's solution (see Denhardt, D. (1966) Biochem. Biophys. Res. Commun. 23, 641-646) containing sonicated denatured salmon sperm DNA at 50μg/ml in 1/2 gal plastic bottles at 50°C on a standard tissue culture roller bottles apparatus for 5-16 hours prior to addition of denatured radio active probe (1-5x107 cpm per filter). Hybridization is carried out during a period of 36 hours at 50°C in 50% formamide/10% dextran sulfate (see Wohl et al supra)/Denhardt's solution/4-fold standard saline citrate (NaCl/Cit/0.1M EDTA/0.1% NaDodSO4 containing sonicated denatured salmon sperm DNA at 25μg/ml.
To remove unhybridized labeled material, the nitrocellulose filters are rinsed twice with 5-fold NaCl/Cit/0.1% NaDodSO4 at 50°C for 10 minutes each and then for 20 minutes with hybridized mixture without salmon sperm DNA and dextran sulfate at 50°C. The filters are rinsed once in NaCl/Cit/0.1% NaDodSO4 at 37°C for 20 minutes, once in NaCl/Cit/0.1% NaDodSO4 at 65°C for 20 minutes, once in half-strength NaCl/Cit/0.1% NaDodSO4 at 65°C for 20 minutes and finally in quarter-strength NaCl/Cit/0.1% NaDodSO4 at 65°C for 15 minutes. The filters are blotted dry and autoradiographed with XR film and DuPont Cronex Lighting Plus screens at -70°C for 1-10 days.
For purposes of comparison a control hybridized restriction enzyme digest of DNA from cells infected with the same type of virulent herpesvirus as that believed to infect the test cells to radio active-labeled nick-translated terminal fragments of the same herpesvirus genome is prepared using the above described procedures, and subjected to autoradiography. The respective autoradiographs of the test specimens are compared to those of the latter known control specimens and matching bands representing terminal fragments of the viral genome indicate the presence of virulent herpesvirus in the test specimen. Whether the test cells are infected with a herpes virus will also be indicated by the correlation of other bands of the respective specimens, the absence of bands representing the terminal fragments indicating that the virus is in the latent state. The invention will be further described in connection with the following specific examples which are given by way of explanation and are not intended to in any way limit the scope of the invention.
Example I The purpose of this example is to determine the presence of HSV-1 in the cellular tissue of the test animals. BALB/c mice were infected with HSV-1(F) by corneal scarification and DNA was extracted from mouse brain and ganglia at acute and latent stages of infection (see Puga, A et al, (1979) Virology 89, 102-111). DNA was extracted from ganglia and brains of latently infected mice, digested with restriction endonuclease BamHI, the DNA fragments were separated by agarose gel electrophoresis, the separated fragments were transferred to nitrocellulose filters and hybr idized to cloned 32p-labeled, n ick-translated fragments of the HSV-1 total viral genome using the procedure which has been detailed hereinabove. The control was similarly prepared using DNA from the HSV-1 (F) strain which was grown on CV-1 and baby hamster kidney (BHK)-21 cells. Autoradiographic exposures ranged from 1 to 6 days.
Fig. 1 shows a selection of acutely infected and latently infected mouse brain and ganglia DNA. Lane 1, the control, represents 1.0 ng. of HSV-1 (F) DNA, purified from extracellar virions and 10μg of uninfected CV-1 cell DNA. Lanes 2 to 6 represent 20 μg of mouse brain DNA taken from five acutely infected mice (6 days post inoculation). Lanes 7, 8 and 10 to 13 represent 20μg of brain DNA taken from six latently infected mice (2 months post inoculation). Lane 9 represents 20μg of DNA extracted from pooled latently infected trigeminal ganglia (2 mo. PI). Lanes 14 and 15 represent 20μg of brain DNA taken from each of two uninfected control animals. Using the above technique where total viron
DNA was used as the probe (see Maniatis et al and Rigby et al, supra), the presence of HSV-1 (F) was detected in the test animals shown in Table I, below:
Figure imgf000011_0002
Figure imgf000011_0001
DNA was extracted from whole brain at various times PI or from brain regions at 2 mo. PI twentyμg samples of brain DNA were digested with BamHI, electrophoresed in agarose gels, transferred to nitrocellulose filters, and hybridized with 32P labeled HVS-1 strains (F) DNA. Genome equivalents was approximated by visual comparison of the sample autoradiographic image with that of reconstructed standards.
(+) denotes a sample positive for HSV-1 DNA with 0.15-0.015 genome equivalents per cell, (++) indicates the sample contained about 0.15 but less than 1.5 genome equivalents per cell. (-) denotes samples that were negative for HSV-1 DNA under the assay conditions.
As can be seen from Table I, Part A, between 2 and 5 months post inoculation (PI), approximately half the mouse brains examined were positive. However, when anatomically defined regions of the brain were examined all of the latent infected mice were positive for HSV-1
(see Part B of Table I). The stem which constitutes about 1/15 (50μg) of the brain DNA appears to be rich in latent viral DNA which is to be expected if the method of brain infection by HSV-1 is via the trigemenal nerve route.
Referring to Fig. 2, the prototype HSV-1 (F) genome there shown consists of a long unique region (UL) and short unique regions (Us). Both unique regions are bounded by inverted repeat regions (TRL, IRL, IRS, TRS). The long and short segments of the genome invert relative to one another forming four isomers. The fragment BamHI SP which spans the junction of the long and short segments of the genome is totally within the IRL and IRS regions resulting in a single BamHI junction fragment for all isomers. Cloned viral fragments used as probes in blot hydridization expermiments are localized along the genome map. The genome illustrated in Fig. 2 is divided into 100 map units, each of which represents 0.98 x 106 daltons or approximately 1.63 kilobases.
EXAMPLE 2 Rather than using total virion DNA as the probe for viral sequences as in Example 1, the probe used was the BamHI fragment SP corresponding to the termini and joint regions (see Fig. 2), which was hybridized with virion DNA (control) and mice brain DNA. Fig. 3 shows a blot hybridization using BamHI (SP) fragment DNA as the probe. By comparison of Lane 1 (viron DNA control) and Lanes 2 to 4 (acute brain DNA), it can be seen that the bands containing the termini of the genome are sub molar in amount. This is not due to isomerization of the viral genome because BamHI cuts with the terminal repeat and therefore each isomer gives the same terminal fragment (see Fig. 2). Lanes 5 to 9 show brains infected wth latent virus and no terminal fragments can be seen. Densitometer scans for the virion, acute and latent autoradiographs showed a molar ratio relative to the PS joint fragment of 0.3 for the P and S terminal fragments during acute infection. That the terminal fragments are reduced in molarity during acute infection of neural tissue with HSV-1 is not unusual. It has previously been noted in infected tissue cells (see Jacob, R.J. et al. (1979) Virology 29. 448-457). However, that no terminal fragments appear to be present in brain or ganglia infected with latent virus was most surprising, and clearly indicates that the viral DNA which enters the latently infected cells is modified during initial phase of latency and does not merely reside inside the cell. As neuronal cells do not undergo DNA replication, it is believed that the viral DNA is not integrated as a unit length molecule into cellular DNA. More probably the viral DNA detected in these latently infected cells represents concatemers of viral DNA which are seen typically as intermediates in rolling circle models of DNA replication. The scientific papers referred to in this specification are incorporated herein in thier entirety by reference. The research work herein described was supported by grant from the National Institute of Neurological and Communicative Disorders and Stroke

Claims

Claims
1. A test for determining whether a herpesvirus present in cellular tissue is in the virulent or latent state which comprises extracting DNA from cells suspected of being infected with a herpesvirus, digesting said DNA with a restriction endonuclease, separating the resulting DNA fragments by size, tranferring said separated DNA fragments to a filter sheet, hybridizing the separated DNA fragments with radio active-labeled nick-translated terminal fragments of the herpes viral genome, subjecting said hybridized DNA fragments to autoradiography, and comparing the pattern of autoradiograph bands obtained, with the pattern of autoradiograph bands produced by the hybridization of a restriction enzyme digest of DNA from cells infected with the same type of virulent herpesvirus with radio active-labeled nick-translated terminal fragments of the herpesvirus genome.
2. The process according to claim 1 in which said herpesvirus comprises herpes simplex virus type 1.
3. The process according to claim 1 in which said radio active-labeled nick-translated terminal fragments of herpesvirus DNA comprise 32p-labeled DNA fragments.
4. The process according to claim 1 in which said DNA fragments resulting from restiction endonuclease digestion are separated by gel electrophoresis, and the resulting pattern of DNA fragments is transferred to a nitrocellulose sheet for hybridization with said radio active-labeled nick-translated fragments of the herpes viral genome.
5. The process according to claim 1 in which said endonuclease comprises BamHI.
6. A test for determining whether herpes simplex virus type 1(HSV-1) present in a cellular tissue is in the virulent or latent state which comprises extracting DNA from cells suspected of being infected with HSV-1, digesting said DNA with the endonuclease BamHI, separating the resulting DNA fragments by gel electrophoresis, transferring the separated DNA fragments to a nitrocellulose sheet, hybridizing the separated DNA fragments with 32p-labeled nick-translated terminal fragments of the HSV-1 viral genome, subjecting said hybridized DNA fragments to autoradiography, and comparing the pattern of autoradiograph bands obtained with the pattern of autoradiograph bands produced by the hybridization of a restriction enzyme digest of DNA from cells infected with virulent HSV-1 with 32p-labeled nick-translated terminal fragments of the HSV-1 viral genome.
PCT/US1983/001209 1982-08-24 1983-08-08 Process for determining whether a herpersvirus is in the virulent or latent state WO1984000979A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41101582A 1982-08-24 1982-08-24

Publications (1)

Publication Number Publication Date
WO1984000979A1 true WO1984000979A1 (en) 1984-03-15

Family

ID=23627207

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1983/001209 WO1984000979A1 (en) 1982-08-24 1983-08-08 Process for determining whether a herpersvirus is in the virulent or latent state

Country Status (3)

Country Link
EP (1) EP0116615A1 (en)
IT (1) IT1168638B (en)
WO (1) WO1984000979A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002101A1 (en) * 1984-10-04 1986-04-10 Biotechnica Limited Determination of identity between two organisms
WO1987002065A1 (en) * 1985-01-08 1987-04-09 Biotal Limited Determination of identity between two organisms
US5604093A (en) * 1986-08-04 1997-02-18 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Human herpesvirus-6(HHV-6)Isolution and Products
USRE38824E1 (en) 1986-08-04 2005-10-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antibodies against human herpes virus-6(HHV-6) and method of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302204A (en) * 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302204A (en) * 1979-07-02 1981-11-24 The Board Of Trustees Of Leland Stanford Junior University Transfer and detection of nucleic acids
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4358535B1 (en) * 1980-12-08 1986-05-13

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Journal of Virology 38(2), May 1981, HELLER et al, "Epstein-Barr Virus DNA IX. Variation Among Viral Dnas from Producer and Nonproducer Infected Cells" p. 632-648 *
Journal of Virology 41(2), February 1982 GALLOWAY et al, "Limited Transcription of the Herpes Simplex Virus Genone when Latent in Human Sensory Ganglia" p. 686-691 *
Journal of Virology, 43(1), July 1982, HUMMEL et al, "Epstein-Barr Virus RNA VIII. Viral RNA in Permissively Infected B95-8 Cells" p. 262-272 *
Nature, 288, 20 November 1980, CABRERA et al, "Herpes Simplix Virus DNA Sequences in the CNS of Latently Infected Mice" p. 288-290 *
Proceedings of the National Academy of Sciences USA, 79(6), June 1982, McDOUGALL et al, "Herpesvirus-Specific RNA and Protein in Carcinoma of the Uterine Cer vix" p. 3853-7 *
Proceedings of the National Academy of Sciences, USA, 78(10), October 1981, FRASER et al, "Herpes Simplex Type 1 DNA in Human Brain Tissue" p. 6461-6465 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002101A1 (en) * 1984-10-04 1986-04-10 Biotechnica Limited Determination of identity between two organisms
WO1987002065A1 (en) * 1985-01-08 1987-04-09 Biotal Limited Determination of identity between two organisms
US5604093A (en) * 1986-08-04 1997-02-18 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Human herpesvirus-6(HHV-6)Isolution and Products
US6018027A (en) * 1986-08-04 2000-01-25 The United States Of America As Represented By The Department Of Health And Human Services Human herpesvirus-6 (HHV-6) isolation and products
US6054283A (en) * 1986-08-04 2000-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antibodies against human herpesvirus-6(HHV-6) and method of use
USRE38824E1 (en) 1986-08-04 2005-10-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antibodies against human herpes virus-6(HHV-6) and method of use

Also Published As

Publication number Publication date
IT8348872A0 (en) 1983-08-23
EP0116615A1 (en) 1984-08-29
IT1168638B (en) 1987-05-20

Similar Documents

Publication Publication Date Title
Kieff et al. Genetic relatedness of type 1 and type 2 herpes simplex viruses
Chang et al. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification
Gissmann et al. Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA
Cheung Detection of pseudorabies virus transcripts in trigeminal ganglia of latently infected swine
Given et al. DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus
Mertz et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study
Lonsdale A rapid technique for distinguishing herpes-simplex virus type 1 from type 2 by restriction-enzyme technology
Ehlers et al. Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers
Kremsdorf et al. Human papillomaviruses associated with epidermodysplasia verruciformis. II. Molecular cloning and biochemical characterization of human papillomavirus 3a, 8, 10, and 12 genomes
Raab-Traub et al. DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus
Chousterman et al. Physical Map of the Channel Catfish Virus Genome: Location of Sites for Restriction Endonucleases Eco RI, Hin dIII, Hpa I, and Xba I
Maitland et al. Restriction endonuclease analysis of DNA from genital isolates of herpes simplex virus type 2
Tenser et al. Detection of herpes simplex virus mRNA in latently infected trigeminal ganglion neurons by in situ hybridization
GB2095833A (en) Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid
Brytting et al. Cytomegalovirus DNA detection of an immediate early protein gene with nested primer oligonucleotides
Dlugosch et al. Diagnosis of acute and latent varicella‐zoster virus infections using the polymerase chain reaction
Pac̆es et al. Cloning and characterization of a repetitive DNA sequence specific for Trichomonas vaginalis
Lancaster et al. Evidence for papillomavirus genus-specific antigens and DNA in laryngeal papilloma
US5230997A (en) Methods of detecting the presence of human herpesvirus-7 infection
Kilvington et al. Differentiation of Acanthamoeba strains from infected corneas and the environment by using restriction endonuclease digestion of whole-cell DNA
Graham et al. Physical map of the origin of defective DNA in herpes simplex virus type 1 DNA
Carbajal et al. Karyotypic diversity among Blastocystis hominis isolates
Ambinder et al. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens
US5075213A (en) Method for detection and prevention of human cytomegalovirus infection
Murakami et al. Role of herpes simplex virus infection in the pathogenesis of facial paralysis in mice

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): AT CH DE GB

AL Designated countries for regional patents

Designated state(s): AT BE CH DE FR GB LU NL SE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642